Report
Valens Research

MMM - Embedded Expectations Analysis - 2021 10 21

3M Company (MMM:USA) currently trades below corporate averages relative to UAFRS-based (Uniform) earnings, with a 19.3x Uniform P/E. At these levels, the market is pricing in profitability to remain stable, but management may have concerns about input cost increases, organic growth, and their margins.

Specifically, management may have concerns about the pace of improvement for the global economy, the lag between input cost increases and their pricing actions, and the challenges in year-over-year comps. Furthermore, they may lack confidence in their ability to expand margins while investing in the business, sustain lower discretionary expenses, and sustain Safety and Industrial quarterly operating income. Also, they may lack confidence in their ability to maintain stationery and office supply organic growth, and drive SG&A efficiency. Finally, they may be overstating the potential of their M&A pipeline and they may be concerned about the sustainability of post-pandemic respirator demand.
Underlying
3M COMPANY

3M is a technology company. The company has four segments: Safety and Industrial, which consists of personal safety, industrial adhesives and tapes, abrasives, closure and masking systems, electrical markets, automotive aftermarket, and roofing granules; Transportation and Electronics, which consists of electronics, automotive and aerospace, commercial solutions, advanced materials, and transportation safety; Health Care, which includes medical solutions, oral care, separation and purification sciences, health information systems, drug delivery systems, and food safety; and Consumer, which consists of home improvement, stationery and office supplies, home care, and consumer health care.

Provider
Valens Research
Valens Research

In 2009, just as the dust was settling from the last major equity and credit market crises, we launched a boutique research firm with the intention of breaking Wall Street’s biases and broken incentives:

  • GAAP and IFRS have failed to provide rules for reliable financial statement reporting
  • Stock analyst recommendations are not grounded in disciplined financial analysis
  • Credit agencies have been set up to grossly fail in their responsibilities to investors and the public markets
  • Utter lack of willingness of major research firms to employ the the most advanced forensic analysis available

We sought to provide investors and company analysts with a source of information that changed all that.
Many years later, our business model remains because little has changed on Wall Street.

  • Corporate credit ratings remain years behind the fundamental underpinnings of company performance
  • Stock analysts continue to make recommendations with deeply inherent biases
  • Research firms have failed to break down the walls between credit, equity, and macroeconomic research
  • The governing accounting bodies have created more leeway for mis-estimates and mis-classifications as financials have become unwieldy and overwhelming

The integrity of Valens Research is founded in our disciplined processes and analytics. No “star” analysts. No corporate advisory relationships. No-nonsense opinions and recommendations.

Analysts
Valens Research

Other Reports on these Companies
Other Reports from Valens Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch